TPG Growth Makes Strategic Growth Investment in K2 Medical Research

June 17, 2024

TPG (TPG Growth) has made a strategic growth investment in K2 Medical Research to partner with management and scale K2’s integrated clinical trial site platform. K2, headquartered in the Orlando/Maitland, Florida area, operates several de novo sites focused on CNS and other complex therapeutic-area trials and has participated in more than 150 studies for over 35 pharma and biotech sponsors; terms were not disclosed.

Buyers
TPG (TPG Growth)
Targets
K2 Medical Research
Location
Florida, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.